Sort
21,281 grants matching “influenza”
Preparedness and Response to Avian and Pandemic Influenza in Rwanda
$300,000Vianney Nizeyimana · Treatment Research Aids Center (Trac) · U51 · FY2007 · IP
Development of a Universal Influenza B Vaccine
$300,000Robert Gerald Whalen · Altravax, Inc. · R43 · FY2015 · AI
Germline-Specific Immunogens for the Induction of Neutralizing Antibodies to HIV-
$300,000Robert Gerald Whalen · Altravax, Inc. · R43 · FY2013 · AI
INNOVATIVE OPTICAL SYSTEM FOR HEMAGGLUTINATION ASSAYS
$300,000Kathy L Rowlen · Indevr, Inc. · R43 · FY2014 · AI
Core_Apt Measure of PCR-based Influenza Vaccine Effectiveness in Inpatient Adults
$300,000Manjusha Gaglani · Scott And White Memorial Hospital · U01 · FY2015 · IP
Gene Gun-delivered RNA vaccines.
$300,000Hannah Frizzell · Orlance, Inc. · R43 · FY2024 · AI
US Hospital Vaccine Effectiveness (VE) Network
$300,000Arnold S Monto · University Of Michigan At Ann Arbor · U01 · FY2015 · IP
Flu vaccine effectiveness in those hospitalized in a large diverse health system
$300,000Richard K Zimmerman · University Of Pittsburgh At Pittsburgh · U01 · FY2015 · IP
Rational Design of Live Attenuated Influenza A Vaccine Candidates
$300,000Eckard Wimmer · Codagenix, Inc. · R41 · FY2013 · AI
POINT-OF-CARE TEST FOR DETECTION OF INFLUENZA
$300,000Andrew Paterson · Luminostics, Inc. · N43 · FY2019 · AI
INNOVATIVE OPTICAL SYSTEM FOR HEMAGGLUTINATION ASSAYS
$300,000Kathy L Rowlen · Indevr, Inc. · R43 · FY2015 · AI
Universal Influenza A/B Vaccine
$300,000Kenneth C Bagley · Orlance, Inc. · R44 · FY2020 · AI
SUSTAINING CAMBODIA'S INFLUENZA SURVEILLANCE NETWORKS AND RESPONSE TO SEASONAL
$300,000An Sam Ung · National Institute Of Public Health · U51 · FY2012 · IP
ENHANCEMENT OF THE CURRENT INFLUENZA SURVEILLANCE AND THE
$300,000Rajae El Aouad · National Institute Of Hygiene · U51 · FY2012 · IP
DEVELOPING SUSTAINABLE INFLUENZA SURVEILLANCE NETWORKS AND RESPONSE TO AVIAN AND
$300,000Remigio Medina Olveda · Research Institute For Tropical Medicine · U51 · FY2012 · IP
A cloud-based system for scalable, privacy-preserving, and interactive immune repertoire analysis in vaccination and infection
$300,000Jun Xiao · Immudx, Llc · R43 · FY2018 · AI
Synergistic panfiloviral entry inhibiting antibody drug conjugates
$300,000Zachary David Aron · Microbiotix, Inc · R43 · FY2018 · AI
OPTIMIZATION OF NOVEL INFLUENZA M2 CHANNEL INHIBITORS
$300,000Ken J McCormack · Arisan Therapeutics, Inc. · R43 · FY2013 · AI
Enhanced Oral Vaccine Delivery Vehicle
$300,000Sean N Tucker · Vaxart, Inc. · R43 · FY2008 · AI
Comparative Spillover Dynamics of Avian Influenza in Endemic Countries
$300,000Peter Daszak · Ecohealth Alliance, Inc. · R56 · FY2012 · TW
Multiplexed vaccine titer test
$300,000David Schwartz · Solulink Biosciences · R43 · FY2011 · AI
Development of Influenza Surveillance Networks Overseas
$300,000Ung Sam An · Royal Government Of Cambodia · U51 · FY2007 · CI
Rapid Viral Diagnostic Test by Digital Plasmonic Nanobubbles
$300,000Zhenpeng Qin · Avsana Labs Incorporated · R41 · FY2022 · AI
Targeted Dendritic Cell Activation through Multi-Adjuvant Liposomes
$300,000Gretchen Jimenez · Molecular Express, Inc. · R43 · FY2013 · AI
Therapeutic antibodies for treatment of hantavirus cardiopulmonary syndrome
$300,000Jason W. Botten · Celdara Medical, Llc · R41 · FY2017 · AI